{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:57:07Z","timestamp":1782471427113,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijrobp.2020.08.046","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:33:01Z","timestamp":1598268781000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease"],"prefix":"10.1016","volume":"109","author":[{"given":"William C.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Maurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishal","family":"Mendiratta-Lala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Matuszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell S.","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall K.","family":"Ten Haken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle C.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.08.046_bib1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: Incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"BJS"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib3","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","volume":"4","author":"Feng","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib8","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/S1470-2045(16)30569-1","article-title":"Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis","volume":"18","author":"Granito","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/lt.25614","article-title":"Liver Imaging Reporting and Data System (LI-RADS) v2018: Impact on categorization and\u00a0hepatocellular carcinoma staging","volume":"25","author":"Chernyak","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2018.09.004","article-title":"Magnetic resonance imaging evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: long term imaging follow-up","volume":"103","author":"Mendiratta-Lala","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijrobp.2017.08.022","article-title":"Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy","volume":"102","author":"Mendiratta-Lala","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0360-3016(82)90459-X","article-title":"Dose fractionation, dose rate and iso-effect relationships for normal tissue responses","volume":"8","author":"Barendsen","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijrobp.2017.11.030","article-title":"Safety and efficacy of accelerated hypofractionation and stereotactic body radiation therapy for hepatocellular carcinoma patients with varying degrees of hepatic impairment","volume":"100","author":"Nabavizadeh","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2017.10.005","article-title":"Modeling of normal tissue complications using imaging and biomarkers after radiation therapy for hepatocellular carcinoma","volume":"100","author":"El Naqa","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: Liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.tranon.2019.04.003","article-title":"Serum levels of hepatocyte growth factor and CD40 ligand predict radiation-induced liver injury","volume":"12","author":"Cuneo","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-018-0065-y","article-title":"Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy","volume":"2","author":"Hong","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib22","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.prro.2013.01.010","article-title":"Hepatic function model based upon HIDA SPECT and dose for physiological adaptive RT","volume":"3","author":"Wang","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijrobp.2012.02.037","article-title":"Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging","volume":"85","author":"Cao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.08.046_bib24","doi-asserted-by":"crossref","first-page":"e3913","DOI":"10.1002\/nbm.3913","article-title":"Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging","volume":"31","author":"Simeth","year":"2018","journal-title":"NMR Biomed"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620341419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620341419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:57:33Z","timestamp":1759744653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620341419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0360301620341419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.046","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}